Cholestyramine
Cholestyramine is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Cholestyramine; Generic name: CHOLESTYRAMINE; Drug class: Bile Acid Sequestrant [EPC].
| Brand name | Cholestyramine |
|---|---|
| Generic name | CHOLESTYRAMINE |
| Drug class | Bile Acid Sequestrant [EPC] |
| Manufacturer | Micro Labs Limited |
| Used for | INDICATIONS AND USAGE 1) Cholestyramine for oral suspension is indicated as adjunctive therapy to diet for the reduction of elevated serum cholesterol in patients with primary hypercholesterolemia (elevated low density lipoprotein [LDL] cholesterol) who do not respond adequately to diet. Cholestyramine for oral suspension may be useful to lower LDL cholesterol in patients who also have hypertriglyceridemia, but it is not indicated where hypertriglyceridemia is the abnormality of most concern. Therapy with lipid-altering agents should be a component of multiple risk factor intervention in those individuals at significantly increased risk for atherosclerotic vascular disease due to hypercholes |
| Dosage | DOSAGE AND ADMINISTRATION The recommended starting adult dose for cholestyramine for oral suspension, USP powder is one pouch once or twice a day. The recommended maintenance dose for cholestyramine for oral suspension, USP is 2 to 4 pouches daily (8 to 16 grams anhydrous cholestyramine resin) divided into two doses. Four grams of anhydrous cholestyramine resin is contained in each measured dose of cholestyramine for oral suspension as follows: Cholestyramine for oral suspension, USP 9 grams It |
| Active ingredient(s) | CHOLESTYRAMINE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=09420793-7357-4194-8172-0b1cddb167fe |